MwanzoTEVA • TLV
add
Teva Pharmaceutical Industries Ltd
Bei iliyotangulia
ILA 6,250.00
Bei za siku
ILA 6,105.00 - ILA 6,218.00
Bei za mwaka
ILA 4,405.00 - ILA 8,431.00
Thamani ya kampuni katika soko
19.58B USD
Wastani wa hisa zilizouzwa
1.16M
Uwiano wa bei na mapato
-
Mgao wa faida
-
Ubadilishanaji wa msingi
TLV
Kwenye habari
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (USD) | Des 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 4.23B | -5.12% |
Matumizi ya uendeshaji wa biashara | 1.21B | 3.52% |
Mapato halisi | -217.00M | -150.58% |
Kiwango cha faida halisi | -5.13 | -153.27% |
Mapato kwa kila hisa | 0.71 | -29.00% |
EBITDA | 1.24B | -18.34% |
Asilimia ya kodi ya mapato | -11.79% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (USD) | Des 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 3.30B | 2.29% |
Jumla ya mali | 39.33B | -9.55% |
Jumla ya dhima | 33.61B | -4.94% |
Jumla ya hisa | 5.72B | — |
hisa zilizosalia | 1.13B | — |
Uwiano wa bei na thamani | 13.19 | — |
Faida inayotokana na mali | 5.98% | — |
Faida inayotokana mtaji | 9.80% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (USD) | Des 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | -217.00M | -150.58% |
Pesa kutokana na shughuli | 575.00M | -51.44% |
Pesa kutokana na uwekezaji | 202.00M | -32.89% |
Pesa kutokana na ufadhili | -675.00M | -17.19% |
Mabadiliko halisi ya pesa taslimu | -19.00M | -101.94% |
Mtiririko huru wa pesa | 180.62M | -85.33% |
Kuhusu
Teva Pharmaceutical Industries Ltd. is an Israeli multinational pharmaceutical company. Teva specializes primarily in generic drugs, but other business interests include branded-drugs, active pharmaceutical ingredients and, to a lesser extent, contract manufacturing services and an out-licensing platform.
Teva's primary branded products include Austedo which is used for the treatment of chorea associated with Huntington's disease and tardive dyskinesia; and Ajovy, used for the preventive treatment of migraine in adults. Additional branded drugs sold by Teva include Copaxone, Bendeka and Treanda, all of which are primarily sold in the United States.
Teva is listed on the Tel Aviv Stock Exchange and the New York Stock Exchange. Its manufacturing facilities are located in Israel, North America, Europe, Australia, and South America. The company is a member of the Pharmaceutical Research and Manufacturers of America.
Teva Pharmaceuticals is the largest generic drug manufacturer in the world. Overall, Teva is the 18th largest pharmaceutical company in the world. Teva has a history of legal trouble in relation to collusion and price-fixing to inflate prices for drugs. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
13 Feb 1944
Tovuti
Wafanyakazi
37,000
